260 related articles for article (PubMed ID: 7600143)
1. Efficacy and safety of ebrotidine compared with ranitidine in patients with duodenal ulcer.
Gabryelewicz A; Konturek SJ; Butruk E; Dzieniszewski J; Marlicz K; Nowak A; Torres J; Marquez M; Ortiz JA
Eur J Gastroenterol Hepatol; 1995 Apr; 7(4):361-6. PubMed ID: 7600143
[TBL] [Abstract][Full Text] [Related]
2. Ebrotidine versus ranitidine in the treatment of acute duodenal ulcer. A multicentre, randomized, double-blind, controlled clinical trial.
Matov V; Metchkov G; Krastev Z; Tchernev K; Mitova R; Márquez M; Torres J; Herrero E; Fillat O; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):555-9. PubMed ID: 9205764
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the efficacy and safety of ebrotidine in the treatment of duodenal ulcer. A multicentre, double-blind, placebo-controlled phase II study.
Gabryelewicz A; Czajkowski A; Skrodzka D; Marlicz K; Luca de Tena F; Aldeguer M; Chantar C; Márquez M; Torres J; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):545-50. PubMed ID: 9205762
[TBL] [Abstract][Full Text] [Related]
4. Ebrotidine versus ranitidine in the healing and prevention of relapse of duodenal ulcer. A multicentre, double-blind, parallel, randomized, controlled study.
Tulassay Z; Döbrönte Z; Farkas I; Juhász L; Simon L; Prónai L; Torres J; Márquez M
Arzneimittelforschung; 1997 Apr; 47(4A):551-5. PubMed ID: 9205763
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of ebrotidine and ranitidine in the treatment of benign gastric ulcer.
Gedliczka O; Bobrzynski A; Rembiasz K; Fillat O; Torres J; Herrero E; Márquez M; Camps F; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):560-4. PubMed ID: 9205765
[TBL] [Abstract][Full Text] [Related]
6. Double-blind comparison of lansoprazole, ranitidine, and placebo in the treatment of acute duodenal ulcer. Lansoprazole Study Group.
Lanza F; Goff J; Scowcroft C; Jennings D; Greski-Rose P
Am J Gastroenterol; 1994 Aug; 89(8):1191-200. PubMed ID: 8053433
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of ebrotidine and ranitidine combined with amoxicillin and metronidazole in the eradication of Helicobacter pylori in patients with duodenal ulcer.
Popiela T; Kulig J; Karcz D; Tabor J; Torres J; Márquez M; Fillat O; Herrero E; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):573-7. PubMed ID: 9205768
[TBL] [Abstract][Full Text] [Related]
8. Nizatidine versus ranitidine in the treatment of peptic ulcer disease: report on the Dutch investigation as part of a European multicentre trial.
Kuipers EJ; Hazenberg HJ; Quik RF; Hazenberg BP; de Zwart PA
Neth J Med; 1990 Aug; 37(1-2):58-62. PubMed ID: 1977089
[TBL] [Abstract][Full Text] [Related]
9. Rabeprazole is superior to ranitidine in the management of active duodenal ulcer disease: results of a double-blind, randomized North American study.
Breiter JR; Riff D; Humphries TJ
Am J Gastroenterol; 2000 Apr; 95(4):936-42. PubMed ID: 10763941
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
Poynard T; Lemaire M; Agostini H
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):661-5. PubMed ID: 8590162
[TBL] [Abstract][Full Text] [Related]
11. The treatment of duodenal and gastric ulcer with ranitidine--a controlled, multicentre clinical trial.
Gibinski K; Nowak A; Gabryelewicz A; Szalaj W; Hasik J; Klincewicz H; Pokora J; Radwan P; Kosecki P; Pachlewski J
Dtsch Z Verdau Stoffwechselkr; 1982; 42(2-3):64-9. PubMed ID: 6286274
[TBL] [Abstract][Full Text] [Related]
12. Double-blind crossover study of ranitidine and ebrotidine in gastro-esophageal reflux disease.
Sito E; Thor PJ; M[aczka M; Lorens K; Konturek SJ; Maj A
J Physiol Pharmacol; 1993 Sep; 44(3):259-72. PubMed ID: 8241527
[TBL] [Abstract][Full Text] [Related]
13. A multicenter, randomized, double-blind study comparing once-daily bedtime administration of famotidine and ranitidine in the short-term treatment of active duodenal ulcer.
Alcalá Santaella R; Guardia J; Pajares J; Pique J; Pita L; Alvárez E; Castellanos P; Guarner L; Ortiz J; Pesquera R
Hepatogastroenterology; 1989 Jun; 36(3):168-71. PubMed ID: 2666293
[TBL] [Abstract][Full Text] [Related]
14. Nizatidine in the short-term treatment of duodenal ulcer--an Italian Multicenter Study.
Bovero E; Poletti M; Boero A; Mura BC; Camarri E; Corradini P; Corsini G; Federici G; Curzio M; Gianquinto G
Hepatogastroenterology; 1987 Dec; 34(6):269-71. PubMed ID: 2892768
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of the safety and efficacy of ebrotidine versus ranitidine and placebo in the prevention of piroxicam-induced gastroduodenal lesions.
Puscas I; Puscas C; Coltau M; Pasca R; Torres J; Márquez M; Herrero E; Fillat O; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):568-72. PubMed ID: 9205767
[TBL] [Abstract][Full Text] [Related]
16. Omeprazole compared with ranitidine once daily in the treatment of duodenal ulcer.
Chelvam P; Goh KL; Leong YP; Leela MP; Yin TP; Ahmad H; Jalleh R; Wong NW; Lee HB; Mahendran T
J Gastroenterol Hepatol; 1989; 4 Suppl 2():53-61. PubMed ID: 2491362
[TBL] [Abstract][Full Text] [Related]
17. Triletide and ranitidine for the management of chronic duodenal ulcer: a controlled clinical investigation.
Gandolfi L; Solmi L
Pharmatherapeutica; 1985; 4(3 Spec No):182-8. PubMed ID: 3903787
[TBL] [Abstract][Full Text] [Related]
18. Gastroprotective and ulcer-healing activities of a new H2-receptor antagonist: ebrotidine.
Brzozowski T; Majka J; Konturek SJ
Digestion; 1992; 51(1):27-36. PubMed ID: 1353465
[TBL] [Abstract][Full Text] [Related]
19. Bedtime administration of lansoprazole does not modify its greater efficacy vs ranitidine in the acute and long-term treatment of duodenal ulcer. Results from a multicentre, randomised, double blind clinical trial.
Russo A; Dattilo M
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):312-9. PubMed ID: 9476183
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of tetracycline and metronidazole alone or with ranitidine on the healing of duodenal ulcer and eradication of Helicobacter pylori. A randomized controlled multicenter study. Tetra-Metro-Ran Study Group.
Massarrat S; Ihm P; Koch HK
Arzneimittelforschung; 1998 Jun; 48(6):686-90. PubMed ID: 9689428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]